Facebook Pixel We aim to make molecular diagnostics based on RT-PCR technology mainstream in India | Bio Spectrum - Business - Lees dit verhaal op Magzter.com

Poging GOUD - Vrij

“We aim to make molecular diagnostics based on RT-PCR technology mainstream in India”

Bio Spectrum

|

September 2020

Backed by Serum Institute of India, Pune based startup Mylab Discovery Solutions is aggressively launching new products in the diagnostic testing space to overcome the challenges posed by the pandemic. After raising funds from the Department of Biotechnology (DBT) and few private investors, the Mylab team has recently developed a fully-automated sample to-PCR-ready system for molecular diagnostics, which is a first in India. Founded in 2016, it is the first company in Asia and second company worldwide to develop and manufacture FDA approved ID-NAT kits for accurate detection of HIV, HBV, HCV and other infections. BioSpectrum India got in touch with Hasmukh Rawal, Managing Director, Mylab Discovery Solutions to find out more about the initiatives being taken up by the startup to combat COVID-19. Edited excerpts;

- Dr Manbeena Chawla

“We aim to make molecular diagnostics based on RT-PCR technology mainstream in India”

Hasmukh Rawal, Managing Director, Mylab Discovery Solutions, Pune

What are the key advantages being offered by the Compact XL system compared to the conventional RT-PCR testing systems?

Compact XL is a sample-to-PCR ready machine for molecular diagnostics that eliminates the huge infrastructure cost of setting up a molecular lab. It is designed to automate lab operations from sample handing to RT-PCR tube preparation. It has flexibility to test multiple parameters with multiple samples at the same time, a never before the feature. With 32 separate channels, dual-deck facility, automated barcode reading, auto fed protocol, self-sanitization, and laboratory information management system (LIMS) connectivity defines Compact XL, as a complete walk-away system. It is a cartridge-based machine and can test multiple samples concurrently. It can be used for a wide range of RNA/DNA-based tests including COVID-19 RT-PCR tests. The machine can take a variety of sample types such as plasma, tissue, sputum, and swab. Other benefits include: Save on real estate costs- no need for multiple rooms and 1000+ sq ft of space. Compact XL reduces footprint to a single room of 100 sqft; Reduced manpower- a traditional lab needs 3-4 skilled molecular biologists. Compact XL allows you to run a lab with just 1 technician; Less Equipment & Consumables- significantly cost-saving on dozens of small equipment and consumables, made obsolete by Compact XL; Zero Manual Error- an automated process with no manual intervention. Accurate material handling and process adherence for reliable results; Low maintenance- Compact XL is a hassle and maintenance free system to save you costs in short and long term. To make India self-reliant in advanced diagnostics, Compact XL is our most ambitious project to date.

MEER VERHALEN VAN Bio Spectrum

Bio Spectrum

Bio Spectrum

MAHE teams up with OpenAI to integrate AI to enhance outcomes

Manipal Academy of Higher Education (MAHE), an Institution of Eminence Deemed to be University in Karnataka, has partnered with OpenAI to integrate advanced artificial intelligence (AI) tools across teaching, research, and academic administration.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Jubilant Bhartia Foundation & McGill University to launch CoE in AI education

The Jubilant Bhartia Foundation in collaboration with McGill University (Canada), has signed a Memorandum of Understanding (MoU) to create the Centre of Excellence (CoE) in artificial intelligence (AI) Education and Research.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Heeding Auditory Warning Signs

By 2050, nearly 2.5 billion people are projected to have some degree of hearing loss, and more than 700 million might require hearing rehabilitation. That's according to the World Health Organization (WHO).

time to read

2 mins

April 2026

Bio Spectrum

Bio Spectrum

Botanic Healthcare on-boards Narahari Naidu as Group Chief Financial Officer

Secundarabad-based Botanic Healthcare, a globally leading nutraceutical company, has announced the appointment of Narahari Naidu as its Group Chief Financial Officer (CFO).

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Paras Health ropes in Balkishan Sharma as Group CHRO and Business Transformation Officer

Paras Health has announced the appointment of Balkishan Sharma as Group Chief Human Resources Officer (Group CHRO) and Business Transformation Officer.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Parse Biosciences unveils Evercode Whole Transcriptome V4 with shorter workflow

Parse Biosciences, a Qiagen company, has announced the launch of the new Evercode Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity and a simplified workflow for single-cell RNA sequencing. Evercode v4 supports extraordinary scalability of up to five million cells and 384 samples in a single run, enabling researchers

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

UK deploys new bone scanners to help prevent fractures

Tens of thousands of patients at risk of osteoporosis and other bone conditions will get faster access to vital bone scans, as 20 new scanners are rolled out across England.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

Cytiva expands Fast Trak process development and validation services facility in India

Cytiva, a Danaher company and a leader in the life sciences industry, has inaugurated an expanded facility for Fast Trak process development (PD) and validation services in Bengaluru.

time to read

1 min

April 2026

Bio Spectrum

Bio Spectrum

ΑΙ TAKES INDIAN PHARMA REINS

The Indian pharmaceutical sector, one of the largest in the world, is undergoing a strategic transformation in the way it operates. As artificial intelligence (AI) gains prominence across the industry, companies are actively adopting Al-driven solutions to enhance efficiency across the entire pharmaceutical ecosystem. Organisations are investing in AI training programmes to keep their workforce future-ready, foster innovation, strengthen supply chains, and transition away from manual record-keeping. In this industry analysis, experts share their perspectives on how AI is shaping the future of the pharma sector.

time to read

10 mins

April 2026

Bio Spectrum

NIH halts arm of clinical trial evaluating potential stroke treatment

The National Institutes of Health (NIH) in the US has stopped an investigational treatment arm of the Comparison of Anti-coagulation and Anti-platelet Therapies for Intracranial Vascular Atherostenosis (CAPTIVA) study, following a regular review by the Data Safety and Monitoring Board (DSMB).

time to read

1 min

April 2026

Translate

Share

-
+

Change font size